|
Peptides
SARS Spike Peptide
Background
SARS Spike (C-Terminus) Peptide
Location
20 amino acids near the carboxy terminus of SARS Spike protein.
Application
SARS Spike peptide is used for blocking the activity of the SARS Spike antibody (Cat. No. 3525). It usually blocks the antibody activity completely in ELISA assays by incubating the peptide with equal volume of antibody for 30 min at 37˚C. It may also act to block the SARS Spike antibody in Western blots.
Tested Application
Bl
Buffer
PBS containing 0.02% sodium azide
Storage
SARS Spike peptide is supplied as 200 μg/ml, 50 μg/vial, in PBS pH7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin and 0.02% sodium azide. Store at -20˚C, stable for one year.
Species Reactivity
n/a
Species
V
Short Description
(CT) SARS Spike peptide
This product belongs to the following categories:
Related Products
References- Edwards SW, Derouet M, Howse M, et al. Regulation of neutrophil apoptosis by Mcl-1. Biochem Soc Trans. 2004; 32:489-92.
- Cuconati A, Mukherjee C, Perez D, et al. DNA damage response and MCL-1 destruction initiate apoptosis in adenovirus-infected cells. Genes and Dev. 2003; 17:2922-32.
- Opferman JT, Letai A, Beard C, et al. Development and maintenance of B and T lymphocytes require antiapoptotic MCL-1. Nature 2003; 426:671-6.
- Kozopas KM, Yang T, Buchan HL, et al. MCL1, a gene expressed in programmed myeloid cell differentiation, has sequence similarity to BCL2. Proc. Natl. Acad. Sci. USA 1993; 90:3516-20.
Datasheet 0801-W
|
|
